Browse by Speciality Area

Hospital Management
Cardiology
Critical Care
Emergency Medicine
Infectious Disease
Integrative Medicine
Internal Medicine
Neurology
Obstetrics/Gynecology
Primary Care/Hospitalist

Browse by Product Type

Subscription Publications
Books & Study Guides

All Products

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Boston Scientific (BSX; Natick, Massachusetts) has made a second equity investment in and extended its exclusive option to acquire EndoTex Interventional Systems (Cupertino, California). In addition, Boston Sci has agreed to acquire EndoTex upon the achievement of certain regulatory milestones.

Acquisitions

Name: Relias Media
Price range: $

January 2, 2015

Reprints

CrowdStrike Crisis Leaves Lessons for Healthcare
Changes to Substance Abuse Disorder Records Rules
Supreme Court Ruling Could Be ‘Sea Change’ for Healthcare
Chevron Ruling Will Bring Uncertainty to Healthcare Compliance
Texas Appellate Court Affirms Dismissal of Medical Malpractice Plaintiff’s Complaint for Failure To Observe Procedural Requirements

Post Date: January 2, 2015

Table of Contents

Financial Disclosure: None of the authors or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients

Subscription Publication

Books & Study Guides

Group & Site Licenses

State CME/CE Requirements